Niki BioSolutions, Inc. (NIKI) Total Non-Current Liabilities (2018 - 2025)
Niki BioSolutions' (NIKI) quarterly Total Non-Current Liabilities came in at $2.0 million in Q4 2025, up 11.75% on a QoQ basis from $1.8 million in Q3 2025.
Niki BioSolutions, Inc. (NIKI) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 6 years of Total Non-Current Liabilities data on file, last reported at $2.0 million in Q4 2025.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $2.0 million (changed N/A YoY) and the FY2025 annual result came in at $4.6 million, up 5.53% from the prior year.
- Total Non-Current Liabilities grew to $2.0 million in Q4 2025, from $1.8 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $12.5 million in Q4 2022 to a low of -$867436.0 in Q2 2023.
- A 5-year average of $3.9 million and a median of $2.0 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 184.94% — and 2023, when it slumped 110.37%.
- Tracing NIKI's Total Non-Current Liabilities over 5 years: stood at $4.4 million in 2021, then soared by 184.94% to $12.5 million in 2022, then slumped by 58.09% to $5.3 million in 2023, then plunged by 84.29% to $825044.0 in 2024, then jumped by 138.04% to $2.0 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $2.0 million (Q4 2025), $1.8 million (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 1.96 Mn |
| Aug 31, 2025 | 1.76 Mn |
| May 31, 2025 | 1.30 Mn |
| May 31, 2024 | 825,044.00 |
| Dec 31, 2023 | 5.25 Mn |
| Jun 30, 2023 | -867,436.00 |
| Dec 31, 2022 | 12.53 Mn |
| Jun 30, 2022 | 8.37 Mn |
| Dec 31, 2021 | 4.40 Mn |
| Dec 31, 2018 | 11.58 Mn |